...
首页> 外文期刊>Bioorganic and medicinal chemistry >Structure-based virtual screening for novel inhibitors of the sarco/endoplasmic reticulum calcium ATPase and their experimental evaluation.
【24h】

Structure-based virtual screening for novel inhibitors of the sarco/endoplasmic reticulum calcium ATPase and their experimental evaluation.

机译:基于结构的虚拟筛选肌节/内质网钙ATP酶抑制剂及其实验评价。

获取原文
获取原文并翻译 | 示例

摘要

A public compound library with 260,000 compounds was screened virtually by computational docking for novel inhibitors of the transmembrane enzyme sarco/endoplasmic reticulum calcium ATPase (SERCA). Docking was performed with the program GOLD in conjunction with a high resolution X-ray crystal structure of SERCA. Compounds that were predicted to be active were tested in bioassays. Nineteen novel compounds were discovered that were capable of inhibiting the ATP hydrolysis activity of SERCA at concentrations below 50 microM. Crucial enzyme/inhibitor interactions were identified by analyzing the docking-predicted binding poses of active compounds. Like other SERCA inhibitors, the newly discovered compounds are of considerable medicinal interest because of their potential for cancer chemotherapy.
机译:通过计算对接筛选跨膜酶sarco /内质网钙ATP酶(SERCA)的新型抑制剂,筛选出包含260,000种化合物的公共化合物库。通过程序GOLD结合SERCA的高分辨率X射线晶体结构进行对接。在生物测定法中测试了预计具有活性的化合物。发现了十九种能够抑制浓度低于50 microM的SERCA的ATP水解活性的新型化合物。通过分析活性化合物的对接预测的结合姿势,可以确定关键的酶/抑制剂相互作用。像其他SERCA抑制剂一样,新发现的化合物由于具有潜在的癌症化学治疗作用,因此具有重要的医学意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号